AP3573A - Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes - Google Patents

Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes

Info

Publication number
AP3573A
AP3573A AP2010005298A AP2010005298A AP3573A AP 3573 A AP3573 A AP 3573A AP 2010005298 A AP2010005298 A AP 2010005298A AP 2010005298 A AP2010005298 A AP 2010005298A AP 3573 A AP3573 A AP 3573A
Authority
AP
ARIPO
Prior art keywords
active ingredient
pharmaceutical compositions
compositions containing
protected against
digestive enzymes
Prior art date
Application number
AP2010005298A
Other languages
English (en)
Other versions
AP2010005298A0 (en
Inventor
Farid Bennis
Jean-Jacques Serrano
Original Assignee
Farid Bennis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farid Bennis filed Critical Farid Bennis
Publication of AP2010005298A0 publication Critical patent/AP2010005298A0/en
Application granted granted Critical
Publication of AP3573A publication Critical patent/AP3573A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AP2010005298A 2007-12-19 2008-12-18 Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes AP3573A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0759971A FR2925333B1 (fr) 2007-12-19 2007-12-19 Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives
PCT/FR2008/052357 WO2009083686A1 (fr) 2007-12-19 2008-12-18 Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives

Publications (2)

Publication Number Publication Date
AP2010005298A0 AP2010005298A0 (en) 2010-06-30
AP3573A true AP3573A (en) 2016-02-08

Family

ID=39671377

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2010005298A AP3573A (en) 2007-12-19 2008-12-18 Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes

Country Status (19)

Country Link
US (1) US8309123B2 (xx)
EP (1) EP2234598A1 (xx)
JP (1) JP5676272B2 (xx)
KR (2) KR101592609B1 (xx)
CN (1) CN101917967B (xx)
AP (1) AP3573A (xx)
AR (1) AR069847A1 (xx)
AU (1) AU2008345474B2 (xx)
BR (1) BRPI0821373B8 (xx)
CA (1) CA2709899C (xx)
EA (1) EA023107B1 (xx)
FR (1) FR2925333B1 (xx)
HK (1) HK1146386A1 (xx)
IL (1) IL206364A (xx)
MA (1) MA31927B1 (xx)
MX (1) MX2010006927A (xx)
TN (1) TN2010000290A1 (xx)
TW (1) TWI461226B (xx)
WO (1) WO2009083686A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120035103A1 (en) * 2010-01-29 2012-02-09 Pillion Dennis J Method for administration of insulin and pharmaceutical composition thereof
US10258583B2 (en) 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
EP3137060B2 (en) 2014-05-01 2023-12-20 Sun Pharmaceutical Industries Ltd Extended release suspension compositions
US9962336B2 (en) 2014-05-01 2018-05-08 Sun Pharmaceutical Industries Limited Extended release suspension compositions
WO2016016845A1 (en) 2014-07-30 2016-02-04 Sun Pharmaceutical Industries Limited Dual-chamber pack
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
WO2016071756A1 (en) * 2014-11-04 2016-05-12 Innopharmax, Inc. Oral administration of unstable or poorly-absorbed drugs
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions
US10369078B2 (en) 2016-05-02 2019-08-06 Sun Pharmaceutical Industries Limited Dual-chamber pack for pharmaceutical compositions
FR3120189A1 (fr) * 2021-03-01 2022-09-02 Farid Bennis Composition pharmaceutique pour une administration par voie orale d’un agoniste du récepteur du GLP-1

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2123524A1 (en) * 1971-01-28 1972-09-08 Nat Res Dev N-blocked insulin derivs - with high water solubility, and the corresp o-blocked cpds
WO1997033531A1 (en) * 1996-03-15 1997-09-18 Unigene Laboratories, Inc. Oral peptide pharmaceutical products
WO2002072075A1 (en) * 2001-03-08 2002-09-19 Unigene Laboratories Inc. Oral peptide pharmaceutical dosage form and method of production
US20020132757A1 (en) * 2000-05-15 2002-09-19 Mccoy Randall E. Formulations for administering calcitonin and processes for preparing the same
US20070154559A1 (en) * 2003-12-24 2007-07-05 Chaul-Min Pai Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692433A (en) * 1983-10-12 1987-09-08 The Regents Of The University Of California Method and composition for regulating serum calcium levels of mammals
EP0179904A1 (en) 1984-05-09 1986-05-07 Medaphore Inc. Oral insulin and a method of making the same
US4693433A (en) * 1986-06-06 1987-09-15 Merrill David Martin Unwind stand for web rolls
US6191105B1 (en) * 1993-05-10 2001-02-20 Protein Delivery, Inc. Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
GB9417524D0 (en) * 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
EP0781142A4 (en) * 1994-09-01 2003-04-09 Allied Medical Res Associates COMPOSITIONS AND METHOD FOR PROVIDING POLYPEPTIDES
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6071539A (en) * 1996-09-20 2000-06-06 Ethypharm, Sa Effervescent granules and methods for their preparation
WO1999016417A1 (en) * 1997-10-01 1999-04-08 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
SE9801495D0 (sv) * 1998-04-28 1998-04-28 Astra Ab Protein formulationa
US6531648B1 (en) * 1998-12-17 2003-03-11 Syngenta Participations Ag Grain processing method and transgenic plants useful therein
SI1031347T1 (en) * 1999-01-27 2002-10-31 Idea Ag Transnasal transport/immunisation with highly adaptable carriers
SE9904121D0 (sv) * 1999-11-15 1999-11-15 Gustaf Jederstroem Hydrophobe biomolecular structure
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
CN1335182A (zh) * 2001-08-08 2002-02-13 华中科技大学 胰岛素口腔喷剂及其制备工艺
GB0119859D0 (en) * 2001-08-15 2001-10-10 Qinetiq Ltd Eye tracking system
US20060258561A1 (en) * 2003-03-13 2006-11-16 Novo Nordisk A/S Novel NPH insulin preparations
EP1765406A4 (en) * 2004-05-21 2012-11-28 Mediplex Corp ADDITIVES FOR IMPROVED MUCOSAL ABSORPTION OF THERAPEUTIC AGENTS
WO2006014673A2 (en) * 2004-07-19 2006-02-09 Nobex Corporation Insulin-oligomer conjugates, formulations and uses thereof
EP2248531A1 (en) * 2004-08-03 2010-11-10 Emisphere Technologies, Inc. Antidiabetic oral insulin-biguanide combination
PL1883394T3 (pl) 2005-05-23 2018-09-28 Sdg, Inc. Konstrukt lipidowy do dostarczania insuliny ssakowi
WO2007032018A1 (en) * 2005-09-15 2007-03-22 Council Of Scientific And Industrial Research pH SENSITIVE NANOPARTICLE FORMULATION FOR ORAL DELIVERY OF PROTEINS/PEPTIDES
US20070134332A1 (en) * 2005-11-21 2007-06-14 Medivas, Llc Polymer particles for delivery of macromolecules and methods of use
WO2007121318A2 (en) * 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2123524A1 (en) * 1971-01-28 1972-09-08 Nat Res Dev N-blocked insulin derivs - with high water solubility, and the corresp o-blocked cpds
WO1997033531A1 (en) * 1996-03-15 1997-09-18 Unigene Laboratories, Inc. Oral peptide pharmaceutical products
US20020132757A1 (en) * 2000-05-15 2002-09-19 Mccoy Randall E. Formulations for administering calcitonin and processes for preparing the same
WO2002072075A1 (en) * 2001-03-08 2002-09-19 Unigene Laboratories Inc. Oral peptide pharmaceutical dosage form and method of production
US20030017203A1 (en) * 2001-03-08 2003-01-23 Unigene Laboratories, Inc. Oral peptide pharmaceutical dosage form and method of production
US20070154559A1 (en) * 2003-12-24 2007-07-05 Chaul-Min Pai Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof

Also Published As

Publication number Publication date
BRPI0821373A2 (pt) 2015-06-16
TW200940107A (en) 2009-10-01
HK1146386A1 (en) 2011-06-03
AU2008345474A1 (en) 2009-07-09
AU2008345474B2 (en) 2014-07-31
FR2925333B1 (fr) 2012-04-13
CN101917967A (zh) 2010-12-15
CA2709899A1 (fr) 2009-07-09
EA023107B1 (ru) 2016-04-29
AR069847A1 (es) 2010-02-24
KR20100095449A (ko) 2010-08-30
JP5676272B2 (ja) 2015-02-25
KR20150132887A (ko) 2015-11-26
TWI461226B (zh) 2014-11-21
WO2009083686A9 (fr) 2009-10-15
MA31927B1 (fr) 2010-12-01
CA2709899C (fr) 2018-01-16
IL206364A (en) 2016-12-29
US20090176691A1 (en) 2009-07-09
FR2925333A1 (fr) 2009-06-26
CN101917967B (zh) 2013-05-22
EA201070746A1 (ru) 2011-02-28
KR101592609B1 (ko) 2016-02-05
JP2011506587A (ja) 2011-03-03
IL206364A0 (en) 2010-12-30
US8309123B2 (en) 2012-11-13
WO2009083686A1 (fr) 2009-07-09
MX2010006927A (es) 2010-12-06
TN2010000290A1 (fr) 2011-11-11
BRPI0821373B1 (pt) 2020-04-22
AP2010005298A0 (en) 2010-06-30
EP2234598A1 (fr) 2010-10-06
BRPI0821373B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
AP3573A (en) Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes
HK1127877A1 (en) Composition containing peptide as the active ingredient
ZA200809002B (en) Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
IL199397A (en) Hetero-ring compounds, pharmaceuticals containing them, and their medicinal products
AU2007299727A8 (en) Self preserved aqueous pharmaceutical compositions
AP2008004671A0 (en) Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
EP2045251A4 (en) COMPOUNDS WHICH CAN INCLUDE THE UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS
AU2013257508A1 (en) Pharmaceutical compositions
EP2078731A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT
SI3984528T1 (sl) Farmacevtski sestavki, ki vsebujejo nilotinib
EP1885334A4 (en) DISCHARGE SYSTEM FOR TWO OR MORE ACTIVE SUBSTANCES AS PART OF ESTABLISHABLE COMPOSITION
EP2130552A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-GRP78 ANTIBODY AS AN ACTIVE SUBSTANCE
EP2045253A4 (en) alpha-amino acid derivative and pharmaceutical agent containing it as an active ingredient
IL194546A0 (en) Arylaminopyridine derivatives and pharmaceutical compositions containing them
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
IL195813A0 (en) Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
IL189614A0 (en) Pharmaceutical compositions of telmisartan
EP2112925A4 (en) SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
GB0614586D0 (en) Pharmaceutical Formulation
IL193211A (en) Derivatives of Indzol-Troaril and pharmaceutical preparations containing them
ZA200900237B (en) Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
ZA200807486B (en) Medicament formulations comprising fluoroquinolones
IL186805A0 (en) Pharmaceutical compositions containing an active vitamin d compound
ZA200901164B (en) Self preserved aqueous pharmaceutical compositions
IL192824A (en) Peptide compounds, pharmaceuticals containing them and their use